Parcourir Liste des unités par auteur "Lamy, Thierry"
Résultats 1-18 de 18
-
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial.
Wang, Michael; Rule, Simon; Zinzani Pier, Luigi; et al.Lancet (London, England), 2017Article dans une revue scientifique -
Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions
Freeman, C; Morschhauser, Franck; Sehn, LH; et al.Blood, 12-2015, 126, 2646-2649Article dans une revue scientifique -
Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma
Wang, Michael; Rule, Simon; Zinzani, Pier Luigi; et al.Leukemia, 26-09-2019, 33, 2762–2766Article dans une revue scientifiquetexte intégral -
Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
Mamez, A-C; Levy, V; Chevallier, Patrice; et al.Bone marrow transplantation, 01-03-2016, 51, 358-364Article dans une revue scientifique -
Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA
Houot, Roch; Soussain, Carole; Tilly, Herve; et al.Ann. Oncol., 2016, 27, 1349-1350Article dans une revue scientifique -
International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20-Positive B Cell PTLD: Clues From the PTLD-1 Trial
Trappe, Ralf; Choquet, Sylvain; Dierickx, Daan; et al.American journal of transplantation, 2015, 15, 1091-1100Article dans une revue scientifique -
Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study
Tilly, Herve; Morschhauser, Franck; Casasnovas, Olivier; et al.The Lancet. Haematology, 2018, 5, E403-E410Article dans une revue scientifique -
Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial
Trneny, Marek; Lamy, Thierry; Walewski, Jan; et al.Lancet Oncol., 2016, 17, 319-331Article dans une revue scientifique -
Pet-adapted treatment for newly diagnosed advanced hodgkin lymphoma (ahl2011): a randomised, multicentre, non-inferiority, phase 3 study
Casasnovas, Rene-Olivier; Bouabdallah, Reda; Brice, Pauline; et al.The Lancet. Oncology, 15-01-2019Article dans une revue scientifique -
A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma
Coiffier, Bertrand; Thieblemont, Catherine; De Guibert, Sophie; et al.British journal of haematology, 2016, 173, 722-730Article dans une revue scientifique -
Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network
Langner-Lemercier, Sophie; Houillier, Caroline; Soussain, Carole; et al.Neuro-oncology, 2016, 18, 1297-1303Article dans une revue scientifique -
Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator''s choice in relapsed or refractory mantle cell lymphoma
Arcaini, Luca; Lamy, Thierry; Walewski, Jan; et al.British journal of haematology, 2018, 180, 224-235Article dans une revue scientifiquetexte intégral -
Radiotherapy or autologous stem-cell transplantation for primary cns lymphoma in patients 60 years of age and younger: results of the intergroup anocef-goelams randomized phase ii precis study
Houillier, Caroline; Taillandier, Luc; Dureau, Sylvain; et al.Journal of clinical oncology . official journal of the American Society of Clinical Oncology, 20-02-2019, JCO1800306Article dans une revue scientifique -
Rituximab after autologous stem-cell transplantation in mantle-cell lymphoma
Le Gouill, S.; Thieblemont, C.; Oberic, L.; et al.The New England journal of medicine, 28-09-2017, 377, 1250-1260Article dans une revue scientifique -
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial
Ribrag, Vincent; Koscielny, Serge; Bosq, Jacques; et al.Lancet (London, England), 2016, 387, 2402-2411Article dans une revue scientifique -
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report
Tout, Mira; Casasnovas, Olivier; Meignan, Michel; et al.Blood, 2017, 129, 2616-2623Article dans une revue scientifique -
Severe chronic primary neutropenia in adults: report on a series of 108 patients
Sicre De Fontbrune, Flore; Moignet, Aline; Beaupain, Blandine; et al.Blood, 01-10-2015, 126, 1643-1650Article dans une revue scientifique -
Severe chronic primary neutropenia in adults: report on a series of 108 patients
Sicre De Fontbrune, Flore; Moignet, Aline; Beaupain, Blandine; et al.Blood, 01-10-2015, 126, 1643-1650Article dans une revue scientifique